Xconomy’s Digital Events →
Adina Mangubat is the chief executive officer of Seattle-based Spiral Genetics.
While everyone in the in the world of sequencing has heard this cynical joke, as an industry, the joke is about to be on us. We have focused our time, energy... Read more »
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.